Barclays Bank Plc $10,000,000,000 Global
Supplement Number 1 dated 15 May 2013 To the Base Prospectus dated 7 December 2012 BARCLAYS BANK PLC (Incorporated with limited liability in England and Wales) $10,000,000,000 GLOBAL COLLATERALISED MEDIUM TERM NOTES supported by a limited recourse undertaking by Barclays CCP Funding LLP This base prospectus supplement (the “Supplement”) is supplemental to, forms part of and must be read in conjunction with, the base prospectus dated 7 December 2012 (the “Base Prospectus”) prepared by Barclays Bank PLC (the “Bank” or the “Issuer”) with respect to its $10,000,000,000 Global Collateralised Medium Term Note Series (the “Global Collateralised Medium Term Note Series”). The Supplement has been approved by the Central Bank of Ireland (the “Central Bank”), as competent authority under Directive 2003/71/EC (the “Prospectus Directive”). The Central Bank only approves this Supplement as meeting the requirements imposed under Irish and EU law pursuant to the Prospectus Directive. This Supplement constitutes a base prospectus supplement for the purposes of the Prospectus Directive. Terms defined in the Base Prospectus have the same meanings when used in this Supplement. The Issuer accepts responsibility for the information contained in this Supplement. To the best of the knowledge of the Issuer (having taken all reasonable care to ensure that such is the case), the information contained in this Supplement is in accordance with the facts and does not omit anything likely to affect the import of such information. This Supplement is supplemental to, and should be read in conjunction with, the Base Prospectus. To the extent that there is any inconsistency between any statement in this Supplement or any statement incorporated by reference into the Base Prospectus, the statements in this Supplement will prevail.
[Show full text]